191 related articles for article (PubMed ID: 25916750)
1. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
[TBL] [Abstract][Full Text] [Related]
2. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
[TBL] [Abstract][Full Text] [Related]
3. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
5. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
6. Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
Koh YW; Jeon YK; Yoon DH; Suh C; Huh J
Tumour Biol; 2016 Jun; 37(6):7507-14. PubMed ID: 26678894
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
[TBL] [Abstract][Full Text] [Related]
8. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.
Mestre F; Gutiérrez A; Rodriguez J; Ramos R; Garcia JF; Martinez-Serra J; Casasus M; Nicolau C; Bento L; Herraez I; Lopez-Perezagua P; Daumal J; Besalduch J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):84-90. PubMed ID: 25475251
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
[TBL] [Abstract][Full Text] [Related]
11. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
Koh YW; Park C; Yoon DH; Suh C; Huh J
Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
[TBL] [Abstract][Full Text] [Related]
13. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
14. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
15. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
[TBL] [Abstract][Full Text] [Related]
16. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
17. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Dinand V; Malik A; Unni R; Arya LS; Pandey RM; Dawar R
Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795
[TBL] [Abstract][Full Text] [Related]
18. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
Neuzillet C; Couvelard A; Tijeras-Raballand A; de Mestier L; de Gramont A; Bédossa P; Paradis V; Sauvanet A; Bachet JB; Ruszniewski P; Raymond E; Hammel P; Cros J
Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563
[TBL] [Abstract][Full Text] [Related]
19. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
[No Abstract] [Full Text] [Related]
20. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]